LFVN Lifevantage

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against LifeVantage Corporation - LFVN

NEW YORK--(BUSINESS WIRE)--

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of LifeVantage Corporation (NASDAQ: LFVN) resulting from allegations that LifeVantage may have issued materially misleading business information to the investing public.

On September 13, 2016, LifeVantage disclosed that it was delaying the release of its fourth quarter and fiscal year 2016 financial results. The delay is due to LifeVantage’s review of its sales into certain international markets and the revenue and income tax and the associated accruals. On this news, shares of LifeVantage fell sharply during intraday trading on September 14, 2016.

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by LifeVantage investors. If you purchased shares of LifeVantage on or before September 13, 2016, please visit the firm’s website at http://www.rosenlegal.com/cases-952.html for more information. You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

EN
14/09/2016

Underlying

LFVNLifevantage

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Lifevantage

 PRESS RELEASE
Free
LFVN LIFEVANTAGE

LifeVantage To Open Iceland Market

LifeVantage To Open Iceland Market Launch delivers innovative business opportunity and top wellness products to Iceland, marking a bold step in European expansion SALT LAKE CITY, July 24, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced its upcoming launch into Iceland expected in September. This marks the company’s continued partnership with its field leadership on international expansion and reinforces its commitment to delivering science-backed wellness so...

July 24, 2025 1 EN
 PRESS RELEASE
Free
LFVN LIFEVANTAGE

LifeVantage Announces Expanded Human Clinical Study for MindBody GLP-1...

LifeVantage Announces Expanded Human Clinical Study for MindBody GLP-1 System™; Findings Increase Average in Natural GLP-1 Production to Over 200%‡‡ Expanded U.S.-clinical research study shows strong results including increased fat loss, improved cravings control, and healthier body composition*‡ SALT LAKE CITY, July 22, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced new results from its second human clinical study on the , revealing even more compelling ou...

July 22, 2025 1 EN
 PRESS RELEASE
Free
LFVN LIFEVANTAGE

LifeVantage Hosts Activate 2025, Unveils New Quarterly Business Campai...

LifeVantage Hosts Activate 2025, Unveils New Quarterly Business Campaign and Incentive to Drive Global Growth SALT LAKE CITY, July 15, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, held its global Activate 2025 virtual event on Saturday, July 12. The event, supported by Consultant-hosted watch parties and local in-person gatherings, provided a dynamic platform to inspire Consultant business engagement and growth. Activate 2025 also celebrated innovation, reinforcing LifeVan...

July 15, 2025 1 EN
 PRESS RELEASE
Free
LFVN LIFEVANTAGE

LifeVantage Declares Quarterly Dividend

LifeVantage Declares Quarterly Dividend SALT LAKE CITY, May 06, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid June 13, 2025 to all stockholders of record at the close of business on May 30, 2025. This represents an increase in the dividend amount by 12.5% over the previous quarter. About LifeVantage Corpo...

May 6, 2025 1 EN
 PRESS RELEASE
Free
LFVN LIFEVANTAGE

LifeVantage Announces Financial Results for the Third Quarter of Fisca...

LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2025 SALT LAKE CITY, May 06, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2025. Third Quarter Fiscal 2025 Summary*: Revenue was $58.4 million, an increase of 21.1% from the prior year period. Excluding the negative impact of foreign currency fluctuations, third quarter revenue increased approximat...

May 6, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch